Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-83,100
Closed -$26.8M 1356
2024
Q3
$26.8M Sell
83,100
-10,600
-11% -$3.47M 0.06% 200
2024
Q2
$29.3M Sell
93,700
-8,400
-8% -$2.47M 0.06% 184
2024
Q1
$29M Sell
102,100
-17,300
-14% -$5.06M 0.05% 186
2023
Q4
$34.4M Sell
119,400
-34,500
-22% -$9.4M 0.06% 200
2023
Q3
$41.4M Buy
+153,900
New +$38.4M 0.07% 146

Other funds holding AMGN

GTS Securities's AMGN Position: Q1 2026 in Review

GTS Securities reduced its Amgen (AMGN) stake by 57% in Q1 2026, selling an estimated $2.4M and leaving 5,053 shares worth $1.78M. The position accounts for 0.06% of the portfolio, ranked #231.

GTS Securities first reported a position in AMGN in Q2 2023 and has held it in 10 quarters since. The position peaked at $3.95M in Q3 2024. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • GTS Securities held 5,053 shares of Amgen worth $1.78M as of Q1 2026.
  • GTS Securities sold 6,745 Amgen shares in Q1 2026, an estimated $2.4M.
  • Amgen made up 0.06% of GTS Securities's portfolio in Q1 2026, its #231 holding.
  • GTS Securities first reported a position in Amgen in Q2 2023 and has held it in 10 quarters since.
  • GTS Securities's Amgen position peaked at $3.95M in Q3 2024.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.